{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:36:21Z","timestamp":1792272981946,"version":"4.4.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001503","name":"Indian Council of Agricultural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001503","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019566","name":"ICAR - National Agricultural Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019566","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.virusres.2022.198909","type":"journal-article","created":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T19:35:45Z","timestamp":1661974545000},"page":"198909","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Antibiotics targeting bacterial protein synthesis reduce the lytic activity of bacteriophages"],"prefix":"10.1016","volume":"321","author":[{"given":"Medhavi","family":"Vashisth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikha","family":"Yashveer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3267-2824","authenticated-orcid":false,"given":"Taruna","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Virmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bidhan Chand","family":"Bera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh Kumar","family":"Vaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3585","key":"10.1016\/j.virusres.2022.198909_bib0001","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1126\/science.141.3585.1065","article-title":"Streptomycin as an antiviral agent: mode of action","volume":"141","author":"Brock","year":"1963","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.virusres.2022.198909_bib0002","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/antibiotics10050471","article-title":"Alternatives to antibiotics: a symposium on the challenges and solutions for animal health and production","volume":"10","author":"Callaway","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.virusres.2022.198909_bib0003","series-title":"Performance Standards for Antimicrobial Susceptibility Testing; 27th Informational Supplement","year":"2017"},{"issue":"8","key":"10.1016\/j.virusres.2022.198909_bib0004","doi-asserted-by":"crossref","first-page":"e799","DOI":"10.1371\/journal.pone.0000799","article-title":"Phage-antibiotic synergy (PAS): \u03b2-lactam and quinolone antibiotics stimulate virulent phage growth","volume":"2","author":"Comeau","year":"2007","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.virusres.2022.198909_bib0005","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/nbt1206-1508","article-title":"Reinventing phage therapy: are the parts greater than the sum?","volume":"24","author":"Fischetti","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.virusres.2022.198909_bib0006","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3389\/fcimb.2018.00376","article-title":"Bacteriophage therapy: clinical trials and regulatory hurdles","author":"Furfaro","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"9","key":"10.1016\/j.virusres.2022.198909_bib0007","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.resmic.2018.04.008","article-title":"Combined bacteriophages and antibiotics as an efficient therapy against VRE Enterococcus faecalis in a mouse model","volume":"169","author":"Gelman","year":"2018","journal-title":"Res. Microbiol."},{"issue":"1","key":"10.1016\/j.virusres.2022.198909_bib0008","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/mdr.2020.0083","article-title":"Environmental phage-based cocktail and antibiotic combination effects on Acinetobacter baumannii biofilm in a human urine model","volume":"27","author":"Grygorcewicz","year":"2021","journal-title":"Microb. Drug Resist."},{"issue":"4","key":"10.1016\/j.virusres.2022.198909_bib0009","doi-asserted-by":"crossref","first-page":"e01462","DOI":"10.1128\/mBio.01462-20","article-title":"Phage-antibiotic synergy is driven by a unique combination of antibacterial mechanism of action and stoichiometry","volume":"11","author":"Gu Liu","year":"2020","journal-title":"MBio"},{"issue":"1","key":"10.1016\/j.virusres.2022.198909_bib0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1099\/00221287-143-1-179","article-title":"Bacteriophage T4 development depends on the physiology of its host Escherichia coli","volume":"143","author":"Hadas","year":"1997","journal-title":"Microbiology"},{"key":"10.1016\/j.virusres.2022.198909_bib0011","unstructured":"Interagency Coordination Group on Antimicrobial Resistance Report, 2019. No time to wait: securing the future from drug-resistant infections. Report to the Secretary-General of the United Nations. World Health Organisation. https:\/\/cdn.who.int\/media\/docs\/default-source\/documents\/no-time-to-wait-securing-the-future-from-drug-resistant-infections-en.pdf?sfvrsn=5b424d7_6&download=true Accessed on 04 May 2022."},{"issue":"1","key":"10.1016\/j.virusres.2022.198909_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-32344-y","article-title":"Enhanced antibacterial effect of the novel T4-like bacteriophage KARL-1 in combination with antibiotics against multi-drug resistant Acinetobacter baumannii","volume":"8","author":"Jansen","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virusres.2022.198909_bib0013","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics9100714","article-title":"Aminoglycoside antibiotics inhibit mycobacteriophage infection","volume":"9","author":"Jiang","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.virusres.2022.198909_bib0014","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s10068-016-0192-6","article-title":"Role of phage-antibiotic combination in reducing antibiotic resistance in Staphylococcus aureus","volume":"25","author":"Jo","year":"2016","journal-title":"Food Sci. Biotechnol."},{"key":"10.1016\/j.virusres.2022.198909_bib0015","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00783-22","article-title":"Aminoglycoside antibiotics inhibit phage infection by blocking an early step of the infection cycle","volume":"13","author":"Kever","year":"2022","journal-title":"MBio"},{"issue":"2","key":"10.1016\/j.virusres.2022.198909_bib0016","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4161\/bact.1.2.14590","article-title":"Pros and cons of phage therapy","volume":"1","author":"Loc-Carrillo","year":"2011","journal-title":"Bacteriophage"},{"key":"10.1016\/j.virusres.2022.198909_bib0017","series-title":"Tackling drug-resistant infections globally: final report and recommendations. The review on antimicrobial resistance","author":"O\u2019Neill","year":"2016"},{"issue":"5","key":"10.1016\/j.virusres.2022.198909_bib0018","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1128\/JB.181.5.1677-1683.1999","article-title":"Model for bacteriophage T4 development in Escherichia coli","volume":"181","author":"Rabinovitch","year":"1999","journal-title":"J. Bacteriol."},{"issue":"6435","key":"10.1016\/j.virusres.2022.198909_bib0019","doi-asserted-by":"crossref","first-page":"eaau4679","DOI":"10.1126\/science.aau4679","article-title":"The challenge of antimicrobial resistance: what economics can contribute","volume":"364","author":"Roope","year":"2019","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.virusres.2022.198909_bib0020","doi-asserted-by":"crossref","first-page":"e13391","DOI":"10.1111\/tid.13391","article-title":"Treatment of recurrent urinary tract infections in a 60-year-old kidney transplant recipient. The use of phage therapy","volume":"23","author":"Rostkowska","year":"2021","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.virusres.2022.198909_bib0021","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nrmicro3096","article-title":"Revenge of the phages: defeating bacterial defences","volume":"11","author":"Samson","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"issue":"10","key":"10.1016\/j.virusres.2022.198909_bib0022","doi-asserted-by":"crossref","first-page":"e00954","DOI":"10.1128\/AAC.00954-17","article-title":"Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection","volume":"61","author":"Schooley","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.virusres.2022.198909_bib0023","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1016\/S1473-3099(18)30513-9","article-title":"Analysis of the clinical antibacterial and antituberculosis pipeline","volume":"19","author":"Theuretzbacher","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virusres.2022.198909_bib0024","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1007\/s00705-018-3811-0","article-title":"Piperacillin and ceftazidime produce the strongest synergistic phage-antibiotic effect in Pseudomonas aeruginosa","volume":"163","author":"Uchiyama","year":"2018","journal-title":"Arch. Virol."},{"issue":"7","key":"10.1016\/j.virusres.2022.198909_bib0025","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1128\/JB.184.7.1888-1894.2002","article-title":"Effects of Escherichia coli physiology on growth of phage T7 in vivo and in silico","volume":"184","author":"You","year":"2002","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.virusres.2022.198909_bib0026","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.00468-21","article-title":"Aminoglycosides antagonize bacteriophage proliferation, attenuating phage suppression of bacterial growth, biofilm formation, and antibiotic resistance","volume":"87","author":"Zuo","year":"2021","journal-title":"Appl. Environ. Microbiol."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170222002374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170222002374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:18:31Z","timestamp":1759155511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170222002374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":26,"alternative-id":["S0168170222002374"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2022.198909","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibiotics targeting bacterial protein synthesis reduce the lytic activity of bacteriophages","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2022.198909","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"198909"}}